BPG is committed to discovery and dissemination of knowledge
Featured Articles
9/10/2021 12:15:30 PM | Browse: 52 | Download: 30
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 64614
Country/Territory Japan
2021-02-21 08:56
Peer-Review Started
2021-02-21 08:59
To Make the First Decision
Return for Revision
2021-05-08 04:11
2021-06-03 13:45
Second Decision
2021-08-11 03:25
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2021-08-11 07:37
Articles in Press
2021-08-11 07:37
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2021-09-02 08:25
Publish the Manuscript Online
2021-09-10 12:09
ISSN 1948-5204 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Review
Article Title Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression
Manuscript Source Invited Manuscript
All Author List Motomichi Fujita, Hideo Suzuki and Fumio Fukai
Funding Agency and Grant Number
Corresponding Author Fumio Fukai, PhD, Professor, Department of Molecular Patho-Physiology, Tokyo University of Science, 2641 Yamazaki, Noda 278-8510, Chiba, Japan. fukai@rs.noda.tus.ac.jp
Key Words Tenascin-C; TNIIIA2; Beta1-integrin; Integrin activation; Colitis-associated colorectal cancer; Colon cancer
Core Tip Exposure of the cryptic functional site TNIIIA2 from the Tenascin-C (TNC) molecule and its potent and sustained activation of beta1-integrins appear to be associated with the development of colon cancer and its malignant progression. Inhibition of the biological function of TNIIIA2 derived from TNC molecule may be a promising strategy for the prevention and treatment of colon cancer.
Publish Date 2021-09-10 12:09
Citation Fujita M, Suzuki H, Fukai F. Involvement of integrin-activating peptides derived from tenascin-C in colon cancer progression. World J Gastrointest Oncol 2021; 13(9): 980-994
URL https://www.wjgnet.com/1948-5204/full/v13/i9/980.htm
DOI https://dx.doi.org/10.4251/wjgo.v13.i9.980
Full Article (PDF) WJGO-13-980.pdf
Full Article (Word) WJGO-13-980.docx
Manuscript File 64614_Auto_Edited-JPY.docx
Answering Reviewers 64614-Answering reviewers.pdf
Audio Core Tip 64614-Audio core tip.m4a
Conflict-of-Interest Disclosure Form 64614-Conflict-of-interest statement.pdf
Copyright License Agreement 64614-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 64614-Language certificate.pdf
Peer-review Report 64614-Peer-review(s).pdf
Scientific Misconduct Check 64614-Bing-Wang JL-1.jpg
Scientific Misconduct Check 64614-Bing-Fan JR-2.png
Scientific Misconduct Check 64614-Scientific misconduct check.pdf
Scientific Editor Work List 64614-Scientific editor work list.pdf